​

2seventy bio Ownership | Who Owns 2seventy bio?

OverviewForecastRevenueFinancialsChartTranscripts

2seventy bio Ownership Summary

2seventy bio is owned by 36.20% institutional investors, 6.71% insiders, and 57.08% retail investors. Kynam capital management, lp is the largest institutional shareholder, holding 11.39% of TSVT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.96% of its assets in 2seventy bio shares.

TSVT Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock2seventy bio36.20%6.71%57.08%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Kynam capital management, lp5.95M11.39%$17.50M
Goldman sachs group4.29M8.22%$12.63M
Blackrock funding, inc. /de4.22M8.08%$12.41M
Vanguard group3.76M7.20%$11.06M
Blackrock3.66M7.03%$14.09M
Morgan stanley3.27M6.28%$12.59M
Newtyn management2.53M4.85%$7.45M
Baker bros. advisors lp2.50M4.78%$7.34M
Casdin capital2.00M3.83%$5.88M
Regeneron pharmaceuticals1.25M2.40%$3.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Western standard788.35K1.54%$2.32M
Newtyn management2.53M1.30%$7.45M
Kynam capital management, lp5.95M1.03%$17.50M
Stonepine capital management300.00K0.71%$882.00K
Venator management575.00K0.49%$1.69M
Casdin capital2.00M0.39%$5.88M
Engine capital management, lp703.97K0.38%$2.07M
Regeneron pharmaceuticals1.25M0.34%$3.69M
Dafna capital management429.25K0.32%$1.26M
Eversept partners, lp1.00M0.26%$2.95M

Top Buyers

HolderShares% AssetsChange
Regeneron pharmaceuticals1.25M0.34%1.25M
Toronto dominion bank800.00K0.00%800.00K
Western standard788.35K1.54%502.42K
Blackrock funding, inc. /de4.22M0.00%352.56K
Point72 asset management310.64K0.00%310.64K

Top Sellers

HolderShares% AssetsChange
Madison avenue partners, lp579.89K0.18%-1.98M
Morgan stanley3.27M0.00%-1.09M
Deutsche bank ag\372.31K0.00%-958.64K
Engine capital management, lp703.97K0.38%-585.98K
Healthcare of ontario pension plan trust fund280.00K0.00%-310.00K

New Positions

HolderShares% AssetsChangeValue
Regeneron pharmaceuticals1.25M0.34%1.25M$3.69M
Toronto dominion bank800.00K0.00%800.00K$2.35M
Point72 asset management310.64K0.00%310.64K$913.27K
Susquehanna fundamental investments93.48K0.00%93.48K$274.83K
Raymond james financial17.55K-17.55K$51.59K

Sold Out

HolderChange
Concord wealth partners-2.00
Tfc financial management-4.00
Farther finance advisors-7.00
Nelson, van denburg & campbell wealth management group-10.00
Capital performance advisors llp-24.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202460-48.28%18,921,267-57.97%360.49%29-27.50%10-72.22%
Sep 30, 20241150.88%45,002,708-5.48%861.03%40-24.53%3719.35%
Jun 30, 2024114-3.39%47,611,9171.78%911.10%5317.78%31-29.55%
Mar 31, 2024118-0.84%46,778,114-2.93%911.03%45-8.16%4422.22%
Dec 31, 2023119-15.60%48,190,228-11.92%940.82%49-35.53%3633.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.53M2.96%-
iShares Russell 2000 ETF1.32M2.52%21.46K
Vanguard Institutional Extnd Mkt Idx Tr780.36K1.51%-
Vanguard Strategic Equity Inv702.79K1.36%-
Xtrackers S&P 500 2xLev Dly Swap ETF 1C655.12K1.27%-
Fidelity Small Cap Index481.64K0.92%-9.02K
JPM Thematics Genetic Thrps C2 Acc USD457.93K0.89%-16.10K
JPM Thematics Genetic Thrps C2 dist USD441.82K0.86%-
iShares Russell 2000 Value ETF442.88K0.85%-
State St Russell Sm/Mid Cp® Indx NL Cl C350.54K0.68%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 17, 2025Snow Jessica Chief Operating OfficerSell$11.36K
Mar 17, 2025Baird William D III President and CEOSell$25.18K
Mar 17, 2025Eatwell Victoria Chief Financial OfficerSell$12.82K
Mar 11, 2025Kynam Global Healthcare Master Fund, LP-Sell$25.35M
Jan 06, 2025Snow Jessica See RemarksSell$5.14K

Insider Transactions Trends

DateBuySell
2025 Q1-15
2024 Q4-4
2024 Q3-4
2024 Q2-3
2024 Q147

TSVT Ownership FAQ

Who Owns 2seventy bio?

2seventy bio shareholders are primarily institutional investors at 36.20%, followed by 6.71% insiders and 57.09% retail investors. The average institutional ownership in 2seventy bio's industry, Biotech Stocks , is 68.48%, which 2seventy bio falls below.

Who owns the most shares of 2seventy bio?

2seventy bio’s largest shareholders are Kynam capital management, lp (5.95M shares, 11.39%), Goldman sachs group (4.29M shares, 8.22%), and Blackrock funding, inc. /de (4.22M shares, 8.08%). Together, they hold 27.69% of 2seventy bio’s total shares outstanding.

Does Blackrock own 2seventy bio?

Yes, BlackRock owns 7.03% of 2seventy bio, totaling 3.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.09M$. In the last quarter, BlackRock decreased its holdings by -244K shares, a -6.26% change.

Who is 2seventy bio’s biggest shareholder by percentage of total assets invested?

Western standard is 2seventy bio’s biggest shareholder by percentage of total assets invested, with 1.54% of its assets in 788.35K 2seventy bio shares, valued at 2.32M$.

Who is the top mutual fund holder of 2seventy bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of 2seventy bio shares, with 2.96% of its total shares outstanding invested in 1.53M 2seventy bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools